| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation of Protein Kinase A Stimulates SUMOylation, Expression, and Transport Activity of Organic Anion Transporter 3
|
Wang, Haoxun
|
|
2019
|
21 |
2 |
p. 1-11
|
artikel
|
| 2 |
Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells
|
Guan, Xiaowen
|
|
2019
|
21 |
2 |
p. 1-10
|
artikel
|
| 3 |
Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling
|
Longest, Worth
|
|
2019
|
21 |
2 |
p. 1-15
|
artikel
|
| 4 |
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report
|
Heimbach, Tycho
|
|
2019
|
21 |
2 |
p. 1-15
|
artikel
|
| 5 |
Dissolution Testing in Drug Product Development: Workshop Summary Report
|
Abend, Andreas
|
|
2019
|
21 |
2 |
p. 1-12
|
artikel
|
| 6 |
Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach
|
Kay, Katherine
|
|
2019
|
21 |
2 |
p. 1-12
|
artikel
|
| 7 |
Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin
|
Chablani, Lipika
|
|
2019
|
21 |
2 |
p. 1-11
|
artikel
|
| 8 |
Incurred Sample Reanalysis: Time to Change the Sample Size Calculation?
|
Rudzki, Piotr J.
|
|
2019
|
21 |
2 |
p. 1-8
|
artikel
|
| 9 |
Moringa Isothiocyanate Activates Nrf2: Potential Role in Diabetic Nephropathy
|
Cheng, David
|
|
2019
|
21 |
2 |
p. 1-14
|
artikel
|
| 10 |
Multiplexed Gene Expression as a Characterization of Bioactivity for Interferon Beta (IFN-β) Biosimilar Candidates: Impact of Innate Immune Response Modulating Impurities (IIRMIs)
|
Mufarrege, Eduardo F.
|
|
2019
|
21 |
2 |
p. 1-11
|
artikel
|
| 11 |
PBPK Absorption Modeling: Establishing the In Vitro–In Vivo Link—Industry Perspective
|
Stillhart, Cordula
|
|
2019
|
21 |
2 |
p. 1-13
|
artikel
|
| 12 |
Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
|
Lim, Hyeong-Seok
|
|
2019
|
21 |
2 |
p. 1-12
|
artikel
|
| 13 |
Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes
|
Nishimuta, Haruka
|
|
2019
|
21 |
2 |
p. 1-13
|
artikel
|
| 14 |
Scientific Considerations for the Review and Approval of First Generic Mometasone Furoate Nasal Suspension Spray in the United States from the Bioequivalence Perspective
|
Liu, Qing
|
|
2019
|
21 |
2 |
p. 1-6
|
artikel
|
| 15 |
Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4
|
Ghassabian, Sussan
|
|
2019
|
21 |
2 |
p. 1-11
|
artikel
|
| 16 |
Survival Prolongation Index as a Novel Metric to Assess Anti-Tumor Activity in Xenograft Models
|
Chandra, Fiona
|
|
2019
|
21 |
2 |
p. 1-9
|
artikel
|
| 17 |
Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products
|
Au, Jessie L.-S.
|
|
2019
|
21 |
2 |
p. 1-12
|
artikel
|
| 18 |
Translational Framework Predicting Tumour Response in Gemcitabine-Treated Patients with Advanced Pancreatic and Ovarian Cancer from Xenograft Studies
|
Garcia-Cremades, Maria
|
|
2019
|
21 |
2 |
p. 1-10
|
artikel
|
| 19 |
Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy
|
Li, Man
|
|
2019
|
21 |
2 |
p. 1-10
|
artikel
|
| 20 |
What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing
|
Polasek, Thomas M.
|
|
2019
|
21 |
2 |
p. 1-9
|
artikel
|
Tijdschrift beschrijving